Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of December 2022, specifically dated December 22, 2022. The document serves as a transaction notification regarding a purchase of company securities by a Person Discharging Managerial Responsibilities (PDMR).
Key Financial Metrics
The filing does not provide consolidated financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It is a regulatory disclosure of a specific insider transaction.
| Transaction Detail | Value |
|---|---|
| Instrument | Ordinary Shares (31 1/2 pence each) |
| Transaction Type | Purchase |
| Volume | 798 Shares |
| Price per Share | £14.535 |
| Total Value | Approx. £11,600 |
| Exchange | London Stock Exchange (XLON) |
Material Changes
The filing does not report material changes to the company's financial position or operations. It discloses a single transaction executed by Mr. Urs Rohner, an Independent Non-Executive Director.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is strictly a statutory notification of a director's share purchase.
Investor Verification Points
- Verify the identity of the purchaser: Mr. Urs Rohner, Independent Non-Executive Director.
- Confirm the transaction date: December 22, 2022.
- Note the transaction volume: 798 Ordinary Shares purchased at £14.535 per share.
- Recognize that this filing does not contain financial performance data for the period.